ORCA-010

N/A

Report date: 2023/10/26 16:40:45

Base Information

Drug NameORCA-010
Drug Alias NameORCA-010
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector > Ad5 vectorBiologics > Oncolytic virus
Mechanisms of ActionCluster of differentiation 80 modulatorsCluster of differentiation 86 modulatorsCell death stimulants +[6] 
TargetsCluster of differentiation 80Cluster of differentiation 86
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrca Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesOrca Therapeutics Bv
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A